Aion Therapeutic Inc.
AION
CNSX
Weiss Ratings | AION - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | AION - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | AION - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.80 | |||
Price History | AION - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 100.00% | |||
60-Day Total Return | 0.00% | |||
90-Day Total Return | 0.00% | |||
Year to Date Total Return | 0.00% | |||
1-Year Total Return | 100.00% | |||
2-Year Total Return | 0.00% | |||
3-Year Total Return | -77.78% | |||
5-Year Total Return | -91.11% | |||
52-Week High % Change | -20.00% | |||
52-Week Low % Change | 300.00% | |||
Price | AION - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.03 | |||
52-Week Low Price | $0.01 | |||
52-Week Low Price (Date) | Apr 20, 2023 | |||
52-Week High Price (Date) | Oct 02, 2023 | |||
Valuation | AION - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 5.99M | |||
Enterprise Value | 7.21M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.01 | |||
Earnings Per Share Growth | -7.14% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 40.00 | |||
Price/Book (Q) | 10.53 | |||
Enterprise Value/Revenue (TTM) | 43.84 | |||
Price | $0.02 | |||
Enterprise Value/EBITDA (TTM) | -24.57 | |||
Enterprise Value/EBIT | -11.02 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | AION - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 315.90M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | AION - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 416-460-3000 | |||
Address | 700 West Georgia Street Vancouver, BC V7Y 1K8 | |||
Website | www.aiontherapeutic.com/ | |||
Country | Canada | |||
Year Founded | 2011 | |||
Profitability | AION - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -397.68% | |||
Profit Margin | -692.21% | |||
Management Effectiveness | AION - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -16.79% | |||
Return on Equity | -- | |||
Income Statement | AION - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 164.50K | |||
Total Revenue (TTM) | 164.50K | |||
Revenue Per Share | $0.00 | |||
Gross Profit (TTM) | 121.30K | |||
EBITDA (TTM) | -293.60K | |||
EBIT (TTM) | -654.20K | |||
Net Income (TTM) | -1.14M | |||
Net Income Avl. to Common (TTM) | -1.14M | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | -74.94% | |||
EPS Diluted (TTM) | -0.01 | |||
EPS Diluted Growth (Q YOY) | 18.18% | |||
Balance Sheet | AION - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 261.10K | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 661.20K | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 772.00K | |||
Current Ratio (Q) | 0.182 | |||
Book Value Per Share (Q) | $0.00 | |||
Total Assets (Q) | 4.40M | |||
Total Current Liabilities (Q) | 3.63M | |||
Total Debt (Q) | 1.52M | |||
Total Liabilities (Q) | 3.63M | |||
Total Common Equity (Q) | 772.00K | |||
Cash Flow | AION - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -215.00K | |||
Cash from Financing (TTM) | 439.70K | |||
Net Change in Cash (TTM) | 258.60K | |||
Levered Free Cash Flow (TTM) | 540.60K | |||
Cash from Operations (TTM) | 84.50K | |||